The monoclonal antitoxin antibodies (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota of mice with Clostridium difficile infection

  1. Džunková, M.
  2. D'Auria, G.
  3. Xu, H.
  4. Huang, J.
  5. Duan, Y.
  6. Moya, A.
  7. Kelly, C.P.
  8. Chen, X.
Aldizkaria:
Frontiers in Cellular and Infection Microbiology

ISSN: 2235-2988

Argitalpen urtea: 2016

Alea: 6

Zenbakia: OCT

Mota: Artikulua

DOI: 10.3389/FCIMB.2016.00119 GOOGLE SCHOLAR lock_openSarbide irekia editor